Search

Your search keyword '"D. Kretzschmar"' showing total 165 results

Search Constraints

Start Over You searched for: Author "D. Kretzschmar" Remove constraint Author: "D. Kretzschmar"
165 results on '"D. Kretzschmar"'

Search Results

1. Course of ankle-brachial-index 12 months after intravascular lithotripsy in calcified peripheral lesions

2. Intravascular lithotripsy in calcified peripheral lesions: the real-world single-center JEN-experience

3. Design, concept and first in-vitro results of the percutaneous, pulsatile left ventricular assist device-PERKAT LV

4. P1746Prehospital logistics and therapy delays in urban vs. rural regions: implications for quality of acute ST-elevation myocardial infarction care

5. P6287Analysis of novel cardiac markers sST2 and IL-33 in chronic heart failure with reduced ejection fraction

6. P1734Physical exercise induces coronary artery collateral growth and affects cardiovascular biomarkers: A biomarker sub-analysis of the EXCITE trial

7. P2793A comparative analysis of the novel cardiac biomarkers sST2, GDF-15, Galectin-3, suPAR, H-FABP and Fetuin-A in heart failure, STEMI and NSTEMI patients

8. 5216Prognostic impact of serum metabolomic profiling of patients with heart failure with reduced ejection fraction

9. P5417Serum levels of fetal tenascin-C variants as novel biomarkers reflecting vascular remodeling and right ventricular dysfunction in pulmonary hypertension

11. P164Serum metabolomic profiling of patients with heart failure with reduced ejection fraction reveals differences between ischemic and dilated cardiomyopathy

12. P3985Analysis of the novel cardiac biomarkers ST2, GDF-15, suPAR, H-FABP and Fetuin A in heart failure with reduced ejection fraction

13. P1414Analysis of the novel cardiac biomarkers sST2, Galectin-3, GDF-15 and Fetuin-A in patients with peripheral artery disease

14. P2742Misdiagnosis of ST-elevation myocardial infarction and treatment delays: impact of case-based training with structured feedback on system quality in a high volume PCI center

16. Clinical Nephrology - Lab methods and other markers

17. An HTS dc SQUID system in competition with induction coils for TEM applications

18. Erythroidine alkaloids: A novel class of phytoestrogens

19. VP5 of infectious bursal disease virus is not essential for viral replication in cell culture

20. An HTS dc SQUID system for geomagnetic prospection

21. How a neuropsychiatric brain bank should be run: A consensus paper of Brainnet Europe II

22. Electrical characterization of individual GaN nanowires

23. Progressive neurodegeneration in Drosophila: a model system

24. Improved characterization of unconsolidated sediments under field conditions based on complex resistivity measurements

26. Transcatheter bicaval valve implantation as interventional treatment in a non-surgical patient with severe tricuspid regurgitation

27. Blood myeloid dendritic cell reduction and differences between myocarditis and dilated cardiomyopathy

28. Reorganized subtotal perfusion blockade of a pulmonary artery without hypertension after successfully lysed massive PE - A case report.

29. Centella asiatica and its caffeoylquinic acid and triterpene constituents increase dendritic arborization of mouse primary hippocampal neurons and improve age-related locomotion deficits in Drosophila .

30. Analysis of interventional treatment options of the common femoral artery - a retrospective single center experience.

31. Identification of Serum Interleukin-22 as Novel Biomarker in Pulmonary Hypertension: A Translational Study.

32. The amyloid precursor protein intracellular domain induces sleep disruptions and its nuclear localization fluctuates in circadian pacemaker neurons in Drosophila and mice.

33. The Jena Method: Perfusionist Independent, Standby Wet-Primed Extracorporeal Membrane Oxygenation (ECMO) Circuit for Immediate Catheterization Laboratory and/or Hybrid Operating Room Deployment.

34. Chlorogenic Acids, Acting via Calcineurin, Are the Main Compounds in Centella asiatica Extracts That Mediate Resilience to Chronic Stress in Drosophila melanogaster .

35. Impact of a VA-ECMO in Combination with an Extracorporeal Cytokine Hemadsorption System in Critically Ill Patients with Cardiogenic Shock-Design and Rationale of the ECMOsorb Trial.

36. Withania somnifera Extracts Promote Resilience against Age-Related and Stress-Induced Behavioral Phenotypes in Drosophila melanogaster; a Possible Role of Other Compounds besides Withanolides.

37. Conundrum of Classifying Subtypes of Pulmonary Hypertension-Introducing a Novel Approach to Classify "Borderline" Patients in a Population with Severe Aortic Stenosis Undergoing TAVI.

38. Chronic blue light leads to accelerated aging in Drosophila by impairing energy metabolism and neurotransmitter levels.

39. Intravascular Lithotripsy in Calcified Peripheral Lesions: Single-Center JEN-Experience.

40. Rationale and Design of JenaMACS-Acute Hemodynamic Impact of Ventricular Unloading Using the Impella CP Assist Device in Patients with Cardiogenic Shock.

41. FTD-associated mutations in Tau result in a combination of dominant and recessive phenotypes.

42. Age-dependent effects of blue light exposure on lifespan, neurodegeneration, and mitochondria physiology in Drosophila melanogaster.

44. A Very Rare Cause of Thrombotic Peripheral Occlusion.

45. Comparison of PCWP and LVEDP Measurements in Patients with Severe Aortic Stenosis Undergoing TAVI-Same Same but Different?

46. Differential Diagnosis between Takotsubo Syndrome and Acute Coronary Syndrome-A Prospective Analysis of Novel Cardiovascular Biomarkers for a More Selective Triage.

47. PNPLA6/NTE, an Evolutionary Conserved Phospholipase Linked to a Group of Complex Human Diseases.

48. Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?

49. EKOS™ Jena Experience: Safety, Feasibility, and Midterm Outcomes of Percutaneous Ultrasound-Assisted Catheter-Directed Thrombolysis in Patients with Intermediate-High-Risk or High-Risk Pulmonary Embolism.

50. A case report of a 37-year-old woman with pulmonary arterial hypertension first presented during her 3rd pregnancy and favourable long-term vasoreactive response.

Catalog

Books, media, physical & digital resources